APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parenteral Nutrition

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Parenteral Nutrition Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025199 pages

Choose your research edition.

Industry ResearchParenteral Nutrition Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Parenteral Nutrition Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Parenteral Nutrition Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parenteral Nutrition Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Parenteral Nutrition Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Parenteral Nutrition market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Parenteral Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parenteral Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parenteral Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Parenteral Nutrition is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Parenteral Nutrition include Lummy, Grand Life Sciences, Xi'an Libang Pharmaceutical, Weixinkang, King York, Kelun Pharma, Grifols, Haisco Pharmaceutical Group and China Meheco Kangli, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parenteral Nutrition market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parenteral Nutrition and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parenteral Nutrition sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parenteral Nutrition market size, projected growth trends, production technologies, key applications, and end-use industries.

Parenteral Nutrition Segment by Company

Lummy

Grand Life Sciences

Xi'an Libang Pharmaceutical

Weixinkang

King York

Kelun Pharma

Grifols

Haisco Pharmaceutical Group

China Meheco Kangli

Lionco Pharmaceutical

BBCA Pharmaceutical

Fresenius Kabi

Otsuka Pharmaceutical

Cisen

B. Braun

Baizheng Pharmaceutical

Baxter

Biokin Pharmaceutical

BBCA Pharmaceutical

JW Pharmaceutical

Aguettant

Parenteral Nutrition Segment by Type

Amino Acid

Alanyl-Glutamine

Heat and Fat Emulsion

Trace Elements

Vitamins

Parenteral Nutrition Segment by Application

One-Chamber

Two-Chamber

Three-Chamber

Parenteral Nutrition Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parenteral Nutrition market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parenteral Nutrition and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parenteral Nutrition.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parenteral Nutrition market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Parenteral Nutrition manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Parenteral Nutrition in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Parenteral Nutrition in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Parenteral Nutrition Industry Trends Table 2. Parenteral Nutrition Industry Drivers Table 3. Parenteral Nutrition Industry Opportunities and Challenges Table 4. Parenteral Nutrition Industry Restraints Table 5. Global Parenteral Nutrition Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Parenteral Nutrition Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Parenteral Nutrition Sales by Manufacturers (M Units) & (2021-2026) Table 8. Global Parenteral Nutrition Sales Market Share by Manufacturers Table 9. Global Parenteral Nutrition Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Parenteral Nutrition Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Parenteral Nutrition Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Parenteral Nutrition Manufacturers, Product Type & Application Table 13. Global Parenteral Nutrition Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Parenteral Nutrition by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Amino Acid Table 17. Major Manufacturers of Alanyl-Glutamine Table 18. Major Manufacturers of Heat and Fat Emulsion Table 19. Major Manufacturers of Trace Elements Table 20. Major Manufacturers of Vitamins Table 21. Global Parenteral Nutrition Sales by Type 2021 VS 2025 VS 2032 (M Units) Table 22. Global Parenteral Nutrition Sales by Type (2021-2026) & (M Units) Table 23. Global Parenteral Nutrition Sales by Type (2027-2032) & (M Units) Table 24. Global Parenteral Nutrition Sales Market Share by Type (2021-2026) Table 25. Global Parenteral Nutrition Sales Market Share by Type (2027-2032) Table 26. Global Parenteral Nutrition Revenue by Type 2021 VS 2025 VS 2032 (M Units) Table 27. Global Parenteral Nutrition Revenue by Type (2021-2026) & (M Units) Table 28. Global Parenteral Nutrition Revenue by Type (2027-2032) & (M Units) Table 29. Global Parenteral Nutrition Revenue Market Share by Type (2021-2026) Table 30. Global Parenteral Nutrition Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of One-Chamber Table 32. Major Manufacturers of Two-Chamber Table 33. Major Manufacturers of Three-Chamber Table 34. Global Parenteral Nutrition Sales by Application 2021 VS 2025 VS 2032 (M Units) Table 35. Global Parenteral Nutrition Sales by Application (2021-2026) & (M Units) Table 36. Global Parenteral Nutrition Sales by Application (2027-2032) & (M Units) Table 37. Global Parenteral Nutrition Sales Market Share by Application (2021-2026) Table 38. Global Parenteral Nutrition Sales Market Share by Application (2027-2032) Table 39. Global Parenteral Nutrition Revenue by Application 2021 VS 2025 VS 2032 (M Units) Table 40. Global Parenteral Nutrition Revenue by Application (2021-2026) & (M Units) Table 41. Global Parenteral Nutrition Revenue by Application (2027-2032) & (M Units) Table 42. Global Parenteral Nutrition Revenue Market Share by Application (2021-2026) Table 43. Global Parenteral Nutrition Revenue Market Share by Application (2027-2032) Table 44. Global Parenteral Nutrition Sales by Region: 2021 VS 2025 VS 2032 (M Units) Table 45. Global Parenteral Nutrition Sales by Region (2021-2026) & (M Units) Table 46. Global Parenteral Nutrition Sales Market Share by Region (2021-2026) Table 47. Global Parenteral Nutrition Sales Forecasted by Region (2027-2032) & (M Units) Table 48. Global Parenteral Nutrition Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 50. North America Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 51. North America Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 52. Europe Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 53. Europe Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 54. Europe Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 55. Asia Pacific Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 56. Asia Pacific Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 57. Asia Pacific Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 58. South America, Middle East and Africa Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Units) Table 59. South America, Middle East and Africa Parenteral Nutrition Sales by Country (2021-2026) & (M Units) Table 60. South America, Middle East and Africa Parenteral Nutrition Sales by Country (2027-2032) & (M Units) Table 61. Global Parenteral Nutrition Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Parenteral Nutrition Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Parenteral Nutrition Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Parenteral Nutrition Revenue Market Share by Region (2021-2026) Table 65. Global Parenteral Nutrition Revenue Market Share by Region (2027-2032) Table 66. Lummy Company Information Table 67. Lummy Business Overview Table 68. Lummy Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Lummy Parenteral Nutrition Product Portfolio Table 70. Lummy Recent Development Table 71. Grand Life Sciences Company Information Table 72. Grand Life Sciences Business Overview Table 73. Grand Life Sciences Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Grand Life Sciences Parenteral Nutrition Product Portfolio Table 75. Grand Life Sciences Recent Development Table 76. Xi'an Libang Pharmaceutical Company Information Table 77. Xi'an Libang Pharmaceutical Business Overview Table 78. Xi'an Libang Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Xi'an Libang Pharmaceutical Parenteral Nutrition Product Portfolio Table 80. Xi'an Libang Pharmaceutical Recent Development Table 81. Weixinkang Company Information Table 82. Weixinkang Business Overview Table 83. Weixinkang Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Weixinkang Parenteral Nutrition Product Portfolio Table 85. Weixinkang Recent Development Table 86. King York Company Information Table 87. King York Business Overview Table 88. King York Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. King York Parenteral Nutrition Product Portfolio Table 90. King York Recent Development Table 91. Kelun Pharma Company Information Table 92. Kelun Pharma Business Overview Table 93. Kelun Pharma Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Kelun Pharma Parenteral Nutrition Product Portfolio Table 95. Kelun Pharma Recent Development Table 96. Grifols Company Information Table 97. Grifols Business Overview Table 98. Grifols Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Grifols Parenteral Nutrition Product Portfolio Table 100. Grifols Recent Development Table 101. Haisco Pharmaceutical Group Company Information Table 102. Haisco Pharmaceutical Group Business Overview Table 103. Haisco Pharmaceutical Group Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Haisco Pharmaceutical Group Parenteral Nutrition Product Portfolio Table 105. Haisco Pharmaceutical Group Recent Development Table 106. China Meheco Kangli Company Information Table 107. China Meheco Kangli Business Overview Table 108. China Meheco Kangli Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. China Meheco Kangli Parenteral Nutrition Product Portfolio Table 110. China Meheco Kangli Recent Development Table 111. Lionco Pharmaceutical Company Information Table 112. Lionco Pharmaceutical Business Overview Table 113. Lionco Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Lionco Pharmaceutical Parenteral Nutrition Product Portfolio Table 115. Lionco Pharmaceutical Recent Development Table 116. BBCA Pharmaceutical Company Information Table 117. BBCA Pharmaceutical Business Overview Table 118. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. BBCA Pharmaceutical Parenteral Nutrition Product Portfolio Table 120. BBCA Pharmaceutical Recent Development Table 121. Fresenius Kabi Company Information Table 122. Fresenius Kabi Business Overview Table 123. Fresenius Kabi Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Fresenius Kabi Parenteral Nutrition Product Portfolio Table 125. Fresenius Kabi Recent Development Table 126. Otsuka Pharmaceutical Company Information Table 127. Otsuka Pharmaceutical Business Overview Table 128. Otsuka Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Otsuka Pharmaceutical Parenteral Nutrition Product Portfolio Table 130. Otsuka Pharmaceutical Recent Development Table 131. Cisen Company Information Table 132. Cisen Business Overview Table 133. Cisen Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Cisen Parenteral Nutrition Product Portfolio Table 135. Cisen Recent Development Table 136. B. Braun Company Information Table 137. B. Braun Business Overview Table 138. B. Braun Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. B. Braun Parenteral Nutrition Product Portfolio Table 140. B. Braun Recent Development Table 141. Baizheng Pharmaceutical Company Information Table 142. Baizheng Pharmaceutical Business Overview Table 143. Baizheng Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Baizheng Pharmaceutical Parenteral Nutrition Product Portfolio Table 145. Baizheng Pharmaceutical Recent Development Table 146. Baxter Company Information Table 147. Baxter Business Overview Table 148. Baxter Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Baxter Parenteral Nutrition Product Portfolio Table 150. Baxter Recent Development Table 151. Biokin Pharmaceutical Company Information Table 152. Biokin Pharmaceutical Business Overview Table 153. Biokin Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Biokin Pharmaceutical Parenteral Nutrition Product Portfolio Table 155. Biokin Pharmaceutical Recent Development Table 156. BBCA Pharmaceutical Company Information Table 157. BBCA Pharmaceutical Business Overview Table 158. BBCA Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. BBCA Pharmaceutical Parenteral Nutrition Product Portfolio Table 160. BBCA Pharmaceutical Recent Development Table 161. JW Pharmaceutical Company Information Table 162. JW Pharmaceutical Business Overview Table 163. JW Pharmaceutical Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. JW Pharmaceutical Parenteral Nutrition Product Portfolio Table 165. JW Pharmaceutical Recent Development Table 166. Aguettant Company Information Table 167. Aguettant Business Overview Table 168. Aguettant Parenteral Nutrition Sales (M Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Aguettant Parenteral Nutrition Product Portfolio Table 170. Aguettant Recent Development Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Parenteral Nutrition Distributors List Table 174. Parenteral Nutrition Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Parenteral Nutrition Product Image Figure 2. Global Parenteral Nutrition Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parenteral Nutrition Market Size (2021-2032) & (US$ Million) Figure 4. Global Parenteral Nutrition Sales (2021-2032) & (M Units) Figure 5. Global Parenteral Nutrition Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Parenteral Nutrition Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Amino Acid Image Figure 9. Alanyl-Glutamine Image Figure 10. Heat and Fat Emulsion Image Figure 11. Trace Elements Image Figure 12. Vitamins Image Figure 13. Global Parenteral Nutrition Sales by Type (2021 VS 2025 VS 2032) & (M Units) Figure 14. Global Parenteral Nutrition Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Parenteral Nutrition Sales Market Share by Type (2021-2032) Figure 16. Global Parenteral Nutrition Revenue by Type (2021 VS 2025 VS 2032) & (M Units) Figure 17. Global Parenteral Nutrition Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Parenteral Nutrition Revenue Market Share by Type (2021-2032) Figure 19. One-Chamber Image Figure 20. Two-Chamber Image Figure 21. Three-Chamber Image Figure 22. Global Parenteral Nutrition Sales by Application (2021 VS 2025 VS 2032) & (M Units) Figure 23. Global Parenteral Nutrition Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Parenteral Nutrition Sales Market Share by Application (2021-2032) Figure 25. Global Parenteral Nutrition Revenue by Application (2021 VS 2025 VS 2032) & (M Units) Figure 26. Global Parenteral Nutrition Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Parenteral Nutrition Revenue Market Share by Application (2021-2032) Figure 28. North America Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 29. North America Parenteral Nutrition Sales Market Share by Country (2021-2032) Figure 30. U.S. Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 31. Canada Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 32. Mexico Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 33. Europe Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 34. Europe Parenteral Nutrition Sales Market Share by Country (2021-2032) Figure 35. Germany Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 36. France Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 37. U.K. Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 38. Italy Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 39. Netherlands Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 40. Asia Pacific Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 41. Asia Pacific Parenteral Nutrition Sales Market Share by Country (2021-2032) Figure 42. China Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 43. Japan Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 44. South Korea Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 45. Southeast Asia Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 46. India Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 47. Australia Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 48. South America, Middle East and Africa Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 49. South America, Middle East and Africa Parenteral Nutrition Sales Market Share by Country (2021-2032) Figure 50. Brazil Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 51. South Africa Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 52. Saudi Arabia Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 53. Turkey Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 54. Argentina Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 55. UAE Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 56. Egypt Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 57. Chile Parenteral Nutrition Sales and Growth Rate (2021-2032) & (M Units) Figure 58. Global Parenteral Nutrition Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Parenteral Nutrition Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Figure 61. North America Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Figure 63. Europe Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Parenteral Nutrition Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Parenteral Nutrition Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Parenteral Nutrition Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Amino Acid
  • Alanyl-Glutamine
  • Heat and Fat Emulsion
  • Trace Elements
  • Vitamins
Applications
  • One-Chamber
  • Two-Chamber
  • Three-Chamber
Companies covered
  • Lummy
  • Grand Life Sciences
  • Xi'an Libang Pharmaceutical
  • Weixinkang
  • King York
  • Kelun Pharma
  • Grifols
  • Haisco Pharmaceutical Group
  • China Meheco Kangli
  • Lionco Pharmaceutical
  • BBCA Pharmaceutical
  • Fresenius Kabi
  • Otsuka Pharmaceutical
  • Cisen
  • B. Braun
  • Baizheng Pharmaceutical
  • Baxter
  • Biokin Pharmaceutical
  • BBCA Pharmaceutical
  • JW Pharmaceutical
  • Aguettant

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Parenteral Nutrition Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Parenteral Nutrition Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Parenteral Nutrition Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Parenteral Nutrition Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Parenteral Nutrition Market Dynamics
  1. 2.1 Parenteral Nutrition Industry Trends
  2. 2.2 Parenteral Nutrition Industry Drivers
  3. 2.3 Parenteral Nutrition Industry Opportunities and Challenges
  4. 2.4 Parenteral Nutrition Industry Restraints
3 Parenteral Nutrition Market by Manufacturers
  1. 3.1 Global Parenteral Nutrition Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Parenteral Nutrition Sales by Manufacturers (2021-2026)
  3. 3.3 Global Parenteral Nutrition Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Parenteral Nutrition Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Parenteral Nutrition Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Parenteral Nutrition Manufacturers, Product Type & Application
  7. 3.7 Global Parenteral Nutrition Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Parenteral Nutrition Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Parenteral Nutrition Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Parenteral Nutrition Tier 1, Tier 2, and Tier 3
4 Parenteral Nutrition Market by Type
  1. 4.1 Parenteral Nutrition Type Introduction
  2. 4.1.1 Amino Acid
  3. 4.1.2 Alanyl-Glutamine
  4. 4.1.3 Heat and Fat Emulsion
  5. 4.1.4 Trace Elements
  6. 4.1.5 Vitamins
  7. 4.2 Global Parenteral Nutrition Sales by Type
  8. 4.2.1 Global Parenteral Nutrition Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Parenteral Nutrition Sales by Type (2021-2032)
  10. 4.2.3 Global Parenteral Nutrition Sales Market Share by Type (2021-2032)
  11. 4.3 Global Parenteral Nutrition Revenue by Type
  12. 4.3.1 Global Parenteral Nutrition Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Parenteral Nutrition Revenue by Type (2021-2032)
  14. 4.3.3 Global Parenteral Nutrition Revenue Market Share by Type (2021-2032)
5 Parenteral Nutrition Market by Application
  1. 5.1 Parenteral Nutrition Application Introduction
  2. 5.1.1 One-Chamber
  3. 5.1.2 Two-Chamber
  4. 5.1.3 Three-Chamber
  5. 5.2 Global Parenteral Nutrition Sales by Application
  6. 5.2.1 Global Parenteral Nutrition Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parenteral Nutrition Sales by Application (2021-2032)
  8. 5.2.3 Global Parenteral Nutrition Sales Market Share by Application (2021-2032)
  9. 5.3 Global Parenteral Nutrition Revenue by Application
  10. 5.3.1 Global Parenteral Nutrition Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Parenteral Nutrition Revenue by Application (2021-2032)
  12. 5.3.3 Global Parenteral Nutrition Revenue Market Share by Application (2021-2032)
6 Global Parenteral Nutrition Sales by Region
  1. 6.1 Global Parenteral Nutrition Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parenteral Nutrition Sales by Region (2021-2032)
  3. 6.2.1 Global Parenteral Nutrition Sales by Region (2021-2026)
  4. 6.2.2 Global Parenteral Nutrition Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Parenteral Nutrition Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Parenteral Nutrition Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Parenteral Nutrition Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Parenteral Nutrition Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Parenteral Nutrition Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Parenteral Nutrition Revenue by Region
  1. 7.1 Global Parenteral Nutrition Revenue by Region
  2. 7.1.1 Global Parenteral Nutrition Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Parenteral Nutrition Revenue by Region (2021-2026)
  4. 7.1.3 Global Parenteral Nutrition Revenue by Region (2027-2032)
  5. 7.1.4 Global Parenteral Nutrition Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Parenteral Nutrition Revenue (2021-2032)
  8. 7.2.2 North America Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Parenteral Nutrition Revenue (2021-2032)
  11. 7.3.2 Europe Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Parenteral Nutrition Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Parenteral Nutrition Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Parenteral Nutrition Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Lummy
  2. 8.1.1 Lummy Company Information
  3. 8.1.2 Lummy Business Overview
  4. 8.1.3 Lummy Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lummy Parenteral Nutrition Product Portfolio
  6. 8.1.5 Lummy Recent Developments
  7. 8.2 Grand Life Sciences
  8. 8.2.1 Grand Life Sciences Company Information
  9. 8.2.2 Grand Life Sciences Business Overview
  10. 8.2.3 Grand Life Sciences Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grand Life Sciences Parenteral Nutrition Product Portfolio
  12. 8.2.5 Grand Life Sciences Recent Developments
  13. 8.3 Xi'an Libang Pharmaceutical
  14. 8.3.1 Xi'an Libang Pharmaceutical Company Information
  15. 8.3.2 Xi'an Libang Pharmaceutical Business Overview
  16. 8.3.3 Xi'an Libang Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Xi'an Libang Pharmaceutical Parenteral Nutrition Product Portfolio
  18. 8.3.5 Xi'an Libang Pharmaceutical Recent Developments
  19. 8.4 Weixinkang
  20. 8.4.1 Weixinkang Company Information
  21. 8.4.2 Weixinkang Business Overview
  22. 8.4.3 Weixinkang Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Weixinkang Parenteral Nutrition Product Portfolio
  24. 8.4.5 Weixinkang Recent Developments
  25. 8.5 King York
  26. 8.5.1 King York Company Information
  27. 8.5.2 King York Business Overview
  28. 8.5.3 King York Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 King York Parenteral Nutrition Product Portfolio
  30. 8.5.5 King York Recent Developments
  31. 8.6 Kelun Pharma
  32. 8.6.1 Kelun Pharma Company Information
  33. 8.6.2 Kelun Pharma Business Overview
  34. 8.6.3 Kelun Pharma Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kelun Pharma Parenteral Nutrition Product Portfolio
  36. 8.6.5 Kelun Pharma Recent Developments
  37. 8.7 Grifols
  38. 8.7.1 Grifols Company Information
  39. 8.7.2 Grifols Business Overview
  40. 8.7.3 Grifols Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Grifols Parenteral Nutrition Product Portfolio
  42. 8.7.5 Grifols Recent Developments
  43. 8.8 Haisco Pharmaceutical Group
  44. 8.8.1 Haisco Pharmaceutical Group Company Information
  45. 8.8.2 Haisco Pharmaceutical Group Business Overview
  46. 8.8.3 Haisco Pharmaceutical Group Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Haisco Pharmaceutical Group Parenteral Nutrition Product Portfolio
  48. 8.8.5 Haisco Pharmaceutical Group Recent Developments
  49. 8.9 China Meheco Kangli
  50. 8.9.1 China Meheco Kangli Company Information
  51. 8.9.2 China Meheco Kangli Business Overview
  52. 8.9.3 China Meheco Kangli Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 China Meheco Kangli Parenteral Nutrition Product Portfolio
  54. 8.9.5 China Meheco Kangli Recent Developments
  55. 8.10 Lionco Pharmaceutical
  56. 8.10.1 Lionco Pharmaceutical Company Information
  57. 8.10.2 Lionco Pharmaceutical Business Overview
  58. 8.10.3 Lionco Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lionco Pharmaceutical Parenteral Nutrition Product Portfolio
  60. 8.10.5 Lionco Pharmaceutical Recent Developments
  61. 8.11 BBCA Pharmaceutical
  62. 8.11.1 BBCA Pharmaceutical Company Information
  63. 8.11.2 BBCA Pharmaceutical Business Overview
  64. 8.11.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BBCA Pharmaceutical Parenteral Nutrition Product Portfolio
  66. 8.11.5 BBCA Pharmaceutical Recent Developments
  67. 8.12 Fresenius Kabi
  68. 8.12.1 Fresenius Kabi Company Information
  69. 8.12.2 Fresenius Kabi Business Overview
  70. 8.12.3 Fresenius Kabi Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fresenius Kabi Parenteral Nutrition Product Portfolio
  72. 8.12.5 Fresenius Kabi Recent Developments
  73. 8.13 Otsuka Pharmaceutical
  74. 8.13.1 Otsuka Pharmaceutical Company Information
  75. 8.13.2 Otsuka Pharmaceutical Business Overview
  76. 8.13.3 Otsuka Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Otsuka Pharmaceutical Parenteral Nutrition Product Portfolio
  78. 8.13.5 Otsuka Pharmaceutical Recent Developments
  79. 8.14 Cisen
  80. 8.14.1 Cisen Company Information
  81. 8.14.2 Cisen Business Overview
  82. 8.14.3 Cisen Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Cisen Parenteral Nutrition Product Portfolio
  84. 8.14.5 Cisen Recent Developments
  85. 8.15 B. Braun
  86. 8.15.1 B. Braun Company Information
  87. 8.15.2 B. Braun Business Overview
  88. 8.15.3 B. Braun Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 B. Braun Parenteral Nutrition Product Portfolio
  90. 8.15.5 B. Braun Recent Developments
  91. 8.16 Baizheng Pharmaceutical
  92. 8.16.1 Baizheng Pharmaceutical Company Information
  93. 8.16.2 Baizheng Pharmaceutical Business Overview
  94. 8.16.3 Baizheng Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Baizheng Pharmaceutical Parenteral Nutrition Product Portfolio
  96. 8.16.5 Baizheng Pharmaceutical Recent Developments
  97. 8.17 Baxter
  98. 8.17.1 Baxter Company Information
  99. 8.17.2 Baxter Business Overview
  100. 8.17.3 Baxter Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Baxter Parenteral Nutrition Product Portfolio
  102. 8.17.5 Baxter Recent Developments
  103. 8.18 Biokin Pharmaceutical
  104. 8.18.1 Biokin Pharmaceutical Company Information
  105. 8.18.2 Biokin Pharmaceutical Business Overview
  106. 8.18.3 Biokin Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Biokin Pharmaceutical Parenteral Nutrition Product Portfolio
  108. 8.18.5 Biokin Pharmaceutical Recent Developments
  109. 8.19 BBCA Pharmaceutical
  110. 8.19.1 BBCA Pharmaceutical Company Information
  111. 8.19.2 BBCA Pharmaceutical Business Overview
  112. 8.19.3 BBCA Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BBCA Pharmaceutical Parenteral Nutrition Product Portfolio
  114. 8.19.5 BBCA Pharmaceutical Recent Developments
  115. 8.20 JW Pharmaceutical
  116. 8.20.1 JW Pharmaceutical Company Information
  117. 8.20.2 JW Pharmaceutical Business Overview
  118. 8.20.3 JW Pharmaceutical Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 JW Pharmaceutical Parenteral Nutrition Product Portfolio
  120. 8.20.5 JW Pharmaceutical Recent Developments
  121. 8.21 Aguettant
  122. 8.21.1 Aguettant Company Information
  123. 8.21.2 Aguettant Business Overview
  124. 8.21.3 Aguettant Parenteral Nutrition Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Aguettant Parenteral Nutrition Product Portfolio
  126. 8.21.5 Aguettant Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parenteral Nutrition Value Chain Analysis
  2. 9.1.1 Parenteral Nutrition Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parenteral Nutrition Production Mode & Process
  6. 9.2 Parenteral Nutrition Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parenteral Nutrition Distributors
  9. 9.2.3 Parenteral Nutrition Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst